Serum levels of IL-6 and IL-1β can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer

Authors: Shuichi Mitsunaga, Masafumi Ikeda, Satoshi Shimizu, Izumi Ohno, J. Furuse, Masatoshi Inagaki, Sayumi Higashi, Hiroyuki Kato, Keiji Terao, Atsushi Ochiai - British Journal of Cancer 2013 cited by 154